Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro.

Recombinant DNA-produced human interferon-alpha 2 inhibited the replication of influenza A and B viruses in primary rhesus monkey kidney cells (RMK). Human interferon-alpha 2 interacted additively or synergistically with rimantadine hydrochloride or ribavirin in reducing the yield of clinical isolates of either H3N2 or H1N1 subtype influenza A viruses. The combination of human interferon-alpha 2 and ribavirin also inhibited the replication of an influenza B virus to a greater extent than either single agent. In addition to drug concentration, the virus inoculum and duration of culture were important variables in determining the degree of inhibition. Single drugs or combinations did not significantly inhibit the growth of uninfected RMK cells, which indicated that the observed interactions with respect to antiviral activity were not due to cell cytotoxicity.
AuthorsF G Hayden, A N Schlepushkin, N L Pushkarskaya
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 25 Issue 1 Pg. 53-7 (Jan 1984) ISSN: 0066-4804 [Print] UNITED STATES
PMID6703684 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Drug Combinations
  • Interferon Type I
  • Ribonucleosides
  • Rimantadine
  • Ribavirin
  • Adamantane
  • Adamantane (analogs & derivatives)
  • Animals
  • Drug Combinations
  • Drug Interactions
  • Influenza A virus (physiology)
  • Interferon Type I (pharmacology)
  • Kidney
  • Macaca mulatta
  • Orthomyxoviridae (physiology)
  • Ribavirin (pharmacology)
  • Ribonucleosides (pharmacology)
  • Rimantadine (pharmacology)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: